The present invention is directed to the field of software relating to the performance of radiation therapy.
Radiation therapy can be used to treat localized cancer. In a typical application, a radiation delivery system has an ionizing radiation device mounted to a movable gantry. The radiation delivery system controls the motion of the radiation device to direct an ionizing radiation beam to a specific point in space commonly referred to as the “machine isocenter.” One aspect of radiation therapy is positioning a patient so that the patient's tumor is located at the machine isocenter. Patient positioning systems can provide information about the location of the tumor relative to the machine isocenter during patient setup procedures. Patient positioning systems use various technologies to locate the tumor, such as optically locating visual markers applied to the patient's skin, or using X-ray analysis to locate metal fiducials subcutaneously implanted in the patient.
To the extent that conventional patient positioning systems are implemented using software, such software tends to support a single medical application, such as positioning patients for treatment of prostate cancer. Such software further tends to be either (1) monolithic, so that it must be executed on a single computer system having prescribed characteristics, or (2) rigidly distributed, so that each of two or more portions of the software must each be executed on a particular single computer system having prescribed characteristics. Where such software is rigidly distributed, different portions of it are typically designed to communicate in limited predefined ways.
Such software can be difficult to adapt over time, such as to (1) change the manner in which it performs its present medical application, such as changing the technology employed to locate the tumor, or (2) support additional medical applications.
In view of the shortcomings of conventional patient positioning software described above, patient positioning software that is more readily adaptable would have significant utility.
A modular software facility for performing patient localization and/or location tracking during radiation therapy (“the facility”) is described. In some embodiments, the facility employs a set of distinct software components that interact in order to collectively perform the tracking function. In some embodiments, these components are substitutable software elements, each performing a different role and providing one or more functions. Components typically isolate dependencies of various types to a minimum number of components, abstracting their detailed operation away from their higher level function. Components typically communicate in well-defined ways, including via a publish and subscribe mechanism.
In some embodiments, the components communicate using standardized mechanism, such as a publish-and-subscribe mechanism. In these embodiments, the dependencies and interactions between components are defined based upon what information each component provides (“publishes”), and what information each component consumes (“subscribes to”). By limiting the dependencies that components may have on one another, this design minimizes the risk that a re-implemented component will fail to interact properly with other existing components. For example, this design may be used to isolate dependencies on the particular technology used to locate the tumor to a small subset of the components, so that the remaining components are free of dependencies on the technology used. If the technology used is subsequently changed, the software facility could be adapted to the new technology by re-implementing only the subset of components. The use of a publish-and-subscribe mechanism enables the set of components consuming particular information from a particular publisher component to expand or contract without any special processing by the publisher component.
In some embodiments, the facility utilizes a publish-and-subscribe mechanism that supports location transparency, such as publish-and-subscribe using NET remoting. In these embodiments, many of the components can be executed on any of a set of connected computer systems, providing a measure of flexibility in the deployment of the facility.
In some embodiments, an update to the facility is performed by replacing a proper subset of the facility's components with re-implemented versions of these components, without re-implementing the remaining components.
In some embodiments, the facility may provide a number of different medical applications, such as patient tracking during radiation therapy for prostate cancer, lung cancer, breast cancer, cancer of the head and neck, liver cancer, pancreatic cancer, cervical cancer, orthopedic cancer, etc. In some such embodiments, each medical application is constituted of a particular set of components. For example, a particular medical application could add a new component not present in other medical applications, or replace a component present in other medical applications with a new implementation of the component. A particular medical application may also include additional hardware to be connected to the computing system. In these embodiments, the facility provides particular medical application by invoking the particular components used by the medical application. In such embodiments, the different applications may be distributed to customers separately. As one example, a new application may be distributed to a customer by providing a customer with a copy of each module.
In some embodiments, the facility may provide a number of different activities relating to a localization and tracking system, including patient set up, patient treatment, patient biofeedback monitoring, patient treatment rehearsal, retrospective treatment data review, treatment data reporting, etc. In various embodiments, these activities are performed as described in U.S. patent application Ser. No. 11/189,542 filed concurrently herewith and entitled USER INTERFACE FOR GUIDED RADIATION THERAPY, which is hereby incorporated by reference in its entirety. In some embodiments, each activity is constituted of a particular set of components. In such embodiments, the different activities may be distributed to customers separately.
In some embodiments, the facility may enable the tracking system to interact with a number of add-on functionalities, such as an accessory for positioning a couch or other structure supporting the patient; an accessory for controlling the intensity of the radiation beam; an accessory for controlling the shape of the radiation beam; an accessory for controlling devices securing the treatment room; an accessory for collecting biofeedback input, such as pulse or respiration; an accessory for performing pre-treatment or intra-treatment imaging; an accessory for supporting the correlation of time-index data for multiple sources; a quality assurance package for one or more accessories, etc. In some such embodiments, each such add-on functionality is constituted of a particular set of components. In some embodiments, the different add-on functionalities may be distributed to customers separately.
In some embodiments, the facility is directed towards tracking a target, i.e., measuring the position and/or the rotation of a target in substantially real time, in a patient in medical applications. In some such embodiments, the facility collects position data of a marker that is substantially fixed relative to the target, determines the location of the marker in an external reference frame (i.e., a reference frame outside the patient), and provides an objective output in the external reference frame that is responsive to the location of the marker. The objective output is repeatedly provided at a frequency/periodicity that adequately tracks the location of the target in real time within a clinically acceptable tracking error range. As such, such tracking enables accurate tracking of the target during diagnostic, planning, treatment or other types of medical procedures. In many specific applications, the objective output is provided within a suitably short latency after collecting the position data and at a sufficiently high frequency to use the data for such medical procedures.
In some or all of the above-described embodiments, the facility provides significant flexibility and adaptability to a system for tracking patient position for radiation therapy.
Console UI component 308 provides a graphical user interface for users in the radiation treatment vault, including patient session management, array positioning, tracking, quality assurance testing, and calibration. Sample behaviors provide by such UI components are described in U.S. Patent Application No. 60/590,699 filed Jul. 23, 2004 entitled USER INTERFACE FOR GUIDED RADIATION THERAPY, and U.S. patent application Ser. No. 11/189,542, filed concurrently herewith and entitled USER INTERFACE FOR GUIDED RADIATION THERAPY, each of which is incorporated herein by reference in its entirety.
Component 305 typically executes on the magnetic localizer front end component 313, typically located inside the radiation treatment vault. Component 308 typically executes on the console PC 312, typically located inside the radiation treatment vault. Components 301, 302, 303, 304, 306, and 307 typically execute on the tracking station 311, typically located outside the radiation treatment vault.
The direction(s) of the arrows between pairs of components indicate the dependency relationship(s) between the components. For example, the double-headed arrow between components 301 and 308 indicates both that component 301 has a dependency on component 308 and component 308 has a dependency on component 301. The single-headed arrow between components 301 and 307 indicates that component 307 has a dependency on component 301. The design for some embodiments omits various inter-component dependencies shown in
The localization system and at least one marker enables real time tracking of a target relative to a machine isocenter or another external reference frame outside of the patient during treatment planning, set up, radiation sessions, and at other times of the radiation therapy process. In many embodiments, real time tracking means collecting position data of the markers, determining the locations of the markers in an external reference frame, and providing an objective output in the external reference frame that is responsive to the location of the markers. The objective output is provided at a frequency that adequately tracks the target in real time and/or a latency that is at least substantially contemporaneous with collecting the position data (e.g., within a generally concurrent period of time).
For example, several embodiments of real time tracking are defined as determining the locations of the markers and calculating the location of the target relative to the machine isocenter at (a) a sufficiently high frequency so that pauses in representations of the target location at a user interface do not interrupt the procedure or are readily discernable by a human, and (b) a sufficiently low latency to be at least substantially contemporaneous with the measurement of the location signals from the markers. Alternatively, real time means that the location system 10 calculates the absolute position of each individual marker 40 and/or the location of the target at a periodicity of 1 ms to 5 seconds, or in many applications at a periodicity of approximately 10-100 ms, or in some specific applications at a periodicity of approximately 20-50 ms. In applications for user interfaces, for example, the periodicity can be 12.5 ms (i.e., a frequency of 80 Hz), 16.667 ms (60 Hz), 20 ms (50 Hz), and/or 50 ms (20 Hz).
Alternatively, real time tracking can further mean that the location system 10 provides the absolute locations of the markers and/or the target to a memory device, user interface, linear accelerator or other device within a latency of 10 ms to 5 seconds from the time the localization signals were transmitted from the markers. In more specific applications, the location system generally provides the locations of the markers and/or target within a latency of about 20-50 ms. The location system accordingly provides real time tracking to monitor the position of the markers and/or the target with respect to an external reference frame in a manner that is expected to enhance the efficacy of radiation therapy because higher radiation doses can be applied to the target and collateral effects to healthy tissue can be mitigated.
Alternatively, real-time tracking can further be defined by the tracking error. Measurements of the position of a moving target are subject to motion-induced error, generally referred to as a tracking error. According to aspects of the present invention, the localization system and at least one marker enable real time tracking of the target relative to the machine isocenter or another external reference frame with a tracking error that is within clinically meaningful limits.
Tracking errors are due to two limitations exhibited by any practical measurement system, specifically (a) latency between the time the target position is sensed and the time the position measurement is made available, and (b) sampling delay due to the periodicity of measurements. For example, if a target is moving at 5 cm/s and a measurement system has a latency of 200 ms, then position measurements will be in error by 1 cm. The error in this example is due to latency alone, independent of any other measurement errors, and is simply due to the fact that the target has moved between the time its position is sensed and the time the position measurement is made available for use. If this exemplary measurement system further has a sampling periodicity of 200 ms (i.e., a sampling frequency of 5 Hz), then the peak tracking error increases to 2 cm, with an average tracking error of 1.5 cm.
In some embodiments, the facility uses structure and/or techniques described in U.S. patent application Ser. No. 11/166,801, filed on Jun. 24, 2005, which is hereby incorporated by reference in its entirety.
It will be appreciated by those skilled in the art that the above-described facility may be straightforwardly adapted or extended in various ways. For example, the facility may be used in conjunction with a wide variety of components, executing on a wide variety of computer systems or other devices, and may provide a variety of different medical applications relating to radiation therapy. While the foregoing description makes reference to preferred embodiments, the scope of the invention is defined solely by the claims that follow and the elements recited therein.
This application claims the benefit of U.S. Patent Application No. 60/590,697 filed Jul. 23, 2004, which is hereby incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3967161 | Lichtblau | Jun 1976 | A |
4023167 | Wahlstrom | May 1977 | A |
4114601 | Abels | Sep 1978 | A |
4123749 | Hartmann et al. | Oct 1978 | A |
4127110 | Bullara | Nov 1978 | A |
4160971 | Jones et al. | Jul 1979 | A |
4222374 | Sampson et al. | Sep 1980 | A |
4260990 | Lichtblau | Apr 1981 | A |
4393872 | Reznik et al. | Jul 1983 | A |
4618822 | Hansen | Oct 1986 | A |
4633250 | Anderson | Dec 1986 | A |
4643196 | Tanaka et al. | Feb 1987 | A |
4696287 | Hortmann et al. | Sep 1987 | A |
4795995 | Eccleston | Jan 1989 | A |
4799495 | Hawkins | Jan 1989 | A |
4909789 | Taguchi et al. | Mar 1990 | A |
4936823 | Colvin et al. | Jun 1990 | A |
4945914 | Allen | Aug 1990 | A |
4994079 | Genese | Feb 1991 | A |
5031634 | Simon | Jul 1991 | A |
5062847 | Barnes | Nov 1991 | A |
5095224 | Renger | Mar 1992 | A |
5099845 | Besz et al. | Mar 1992 | A |
5107862 | Fabian et al. | Apr 1992 | A |
5142292 | Chang | Aug 1992 | A |
5170055 | Carroll et al. | Dec 1992 | A |
5325873 | Hirschi et al. | Jul 1994 | A |
5353804 | Kornberg et al. | Oct 1994 | A |
5409004 | Sloan | Apr 1995 | A |
5423334 | Jordan | Jun 1995 | A |
5425367 | Shapiro | Jun 1995 | A |
5425382 | Golden et al. | Jun 1995 | A |
5446548 | Gerig et al. | Aug 1995 | A |
5509900 | Kirkman | Apr 1996 | A |
5528651 | Leksell | Jun 1996 | A |
5626630 | Markowitz et al. | May 1997 | A |
5638819 | Manwaring et al. | Jun 1997 | A |
5651043 | Tsuyuki et al. | Jul 1997 | A |
5680106 | Schrott | Oct 1997 | A |
5697384 | Miyawaki et al. | Dec 1997 | A |
5707362 | Yoon | Jan 1998 | A |
5707390 | Bonutti | Jan 1998 | A |
5711299 | Manwaring et al. | Jan 1998 | A |
5727552 | Ryan | Mar 1998 | A |
5735795 | Young et al. | Apr 1998 | A |
5748767 | Raab | May 1998 | A |
5754623 | Seki et al. | May 1998 | A |
5757881 | Hughes | May 1998 | A |
5764052 | Renger | Jun 1998 | A |
5769861 | Vilsmeier | Jun 1998 | A |
5810851 | Yoon | Sep 1998 | A |
5815076 | Herring | Sep 1998 | A |
5840148 | Campbell | Nov 1998 | A |
5868673 | Vesely | Feb 1999 | A |
5879297 | Haynor et al. | Mar 1999 | A |
5910144 | Hayashi | Jun 1999 | A |
5928137 | Green et al. | Jul 1999 | A |
5951481 | Evans | Sep 1999 | A |
5957934 | Rapoport et al. | Sep 1999 | A |
5989265 | Bouquet De La Joliniere et al. | Nov 1999 | A |
6026818 | Blair | Feb 2000 | A |
6059734 | Yoon | May 2000 | A |
6061644 | Leis | May 2000 | A |
6067465 | Foo | May 2000 | A |
6076008 | Bucholz | Jun 2000 | A |
6081238 | Alicot | Jun 2000 | A |
6082366 | Andra et al. | Jul 2000 | A |
6144875 | Schweikard et al. | Nov 2000 | A |
6161009 | Skurdal et al. | Dec 2000 | A |
6198963 | Haim et al. | Mar 2001 | B1 |
6246900 | Cosman et al. | Jun 2001 | B1 |
6307473 | Zampini et al. | Oct 2001 | B1 |
6325758 | Carol et al. | Dec 2001 | B1 |
6353655 | Siochi | Mar 2002 | B1 |
6359959 | Butler et al. | Mar 2002 | B1 |
6363940 | Krag | Apr 2002 | B1 |
6371379 | Dames | Apr 2002 | B1 |
6377162 | Delestienne et al. | Apr 2002 | B1 |
6381485 | Hunter et al. | Apr 2002 | B1 |
6385286 | Fitchard et al. | May 2002 | B1 |
6385288 | Kanematsu | May 2002 | B1 |
6393096 | Carol et al. | May 2002 | B1 |
6405072 | Cosman | Jun 2002 | B1 |
6416520 | Kynast et al. | Jul 2002 | B1 |
6501981 | Schweikard et al. | Dec 2002 | B1 |
6510199 | Hughes et al. | Jan 2003 | B1 |
6526415 | Smith et al. | Feb 2003 | B2 |
6535756 | Simon et al. | Mar 2003 | B1 |
6650930 | Ding et al. | Nov 2003 | B2 |
6662036 | Cosman | Dec 2003 | B2 |
6675810 | Krag | Jan 2004 | B2 |
6698433 | Krag | Mar 2004 | B2 |
6711431 | Sarin et al. | Mar 2004 | B2 |
6812842 | Dimmer | Nov 2004 | B2 |
6822570 | Dimmer et al. | Nov 2004 | B2 |
6838990 | Dimmer | Jan 2005 | B2 |
6882947 | Levin | Apr 2005 | B2 |
6918919 | Krag | Jul 2005 | B2 |
6934356 | Satheesan et al. | Aug 2005 | B1 |
6937696 | Mostafavi | Aug 2005 | B1 |
6977504 | Wright et al. | Dec 2005 | B2 |
6993112 | Hesse et al. | Jan 2006 | B2 |
6999555 | Morf et al. | Feb 2006 | B2 |
7026927 | Wright et al. | Apr 2006 | B2 |
7027707 | Imaki et al. | Apr 2006 | B2 |
7072707 | Galloway, Jr. et al. | Jul 2006 | B2 |
7142905 | Slayton et al. | Nov 2006 | B2 |
7154991 | Earnst et al. | Dec 2006 | B2 |
7174201 | Govari et al. | Feb 2007 | B2 |
7206626 | Quaid, III | Apr 2007 | B2 |
7206627 | Abovitz et al. | Apr 2007 | B2 |
7213009 | Pestotnik et al. | May 2007 | B2 |
7221733 | Takai et al. | May 2007 | B1 |
7289599 | Seppi et al. | Oct 2007 | B2 |
7289839 | Dimmer et al. | Oct 2007 | B2 |
7447643 | Olson et al. | Nov 2008 | B1 |
7557353 | Black et al. | Jul 2009 | B2 |
7606405 | Sawyer et al. | Oct 2009 | B2 |
20020065461 | Cosman | May 2002 | A1 |
20020165443 | Mori | Nov 2002 | A1 |
20020193685 | Mate | Dec 2002 | A1 |
20030052785 | Gisselberg | Mar 2003 | A1 |
20030088178 | Owens et al. | May 2003 | A1 |
20030192557 | Krag | Oct 2003 | A1 |
20030206610 | Collins | Nov 2003 | A1 |
20030206614 | Kendrick et al. | Nov 2003 | A1 |
20040068182 | Misra | Apr 2004 | A1 |
20040116804 | Mostafavi | Jun 2004 | A1 |
20040122311 | Cosman | Jun 2004 | A1 |
20040125916 | Herron et al. | Jul 2004 | A1 |
20040127787 | Dimmer et al. | Jul 2004 | A1 |
20040133101 | Mate et al. | Jul 2004 | A1 |
20040138555 | Krag | Jul 2004 | A1 |
20040158146 | Mate et al. | Aug 2004 | A1 |
20040176931 | Wright et al. | Sep 2004 | A1 |
20050059884 | Krag | Mar 2005 | A1 |
20050059887 | Mostafavi et al. | Mar 2005 | A1 |
20050077459 | Engler et al. | Apr 2005 | A1 |
20050151649 | Wright et al. | Jul 2005 | A1 |
20050154280 | Wright et al. | Jul 2005 | A1 |
20050154283 | Wright et al. | Jul 2005 | A1 |
20050154284 | Wright et al. | Jul 2005 | A1 |
20050154293 | Gisselberg et al. | Jul 2005 | A1 |
20050195084 | Dimmer | Sep 2005 | A1 |
20050234332 | Murphy | Oct 2005 | A1 |
20050261570 | Mate et al. | Nov 2005 | A1 |
20060058648 | Meier et al. | Mar 2006 | A1 |
20060063999 | Herron et al. | Mar 2006 | A1 |
20060074301 | Meier et al. | Apr 2006 | A1 |
20060074302 | Meier et al. | Apr 2006 | A1 |
20060078086 | Riley et al. | Apr 2006 | A1 |
20060079764 | Wright et al. | Apr 2006 | A1 |
20060100509 | Wright et al. | May 2006 | A1 |
20070161884 | Black et al. | Jul 2007 | A1 |
Number | Date | Country |
---|---|---|
19914455 | Oct 2000 | DE |
0531081 | Jan 1992 | EP |
26335259 | Feb 1990 | FR |
2686499 | Jul 1993 | FR |
8-166446 | Jun 1996 | JP |
WO-9525475 | Sep 1995 | WO |
WO-9712553 | Apr 1997 | WO |
WO-9830166 | Jul 1998 | WO |
WO-9838908 | Sep 1998 | WO |
WO-9840026 | Sep 1998 | WO |
WO-9930182 | Jun 1999 | WO |
WO-9933406 | Jul 1999 | WO |
WO-9940869 | Aug 1999 | WO |
WO-9958044 | Nov 1999 | WO |
WO-9958065 | Nov 1999 | WO |
WO-0038579 | Jul 2000 | WO |
WO-0051514 | Sep 2000 | WO |
WO-0053115 | Sep 2000 | WO |
WO-0065989 | Nov 2000 | WO |
WO-0239917 | May 2002 | WO |
WO-0239918 | May 2002 | WO |
Number | Date | Country | |
---|---|---|---|
20060052694 A1 | Mar 2006 | US |
Number | Date | Country | |
---|---|---|---|
60590697 | Jul 2004 | US |